VioQuest Pharmaceuticals, Inc.·4

Dec 4, 11:50 AM ET

VioQuest Pharmaceuticals, Inc. 4

4 · VioQuest Pharmaceuticals, Inc. · Filed Dec 4, 2007

Insider Transaction Report

Form 4
Period: 2007-12-04
BECKER MICHAEL D
DirectorPresident and CEO
Transactions
  • Award

    Stock Options

    2007-12-04+299,754299,754 total
    Exercise: $0.30Exp: 2017-11-21Common Stock (299,754 underlying)
Holdings
  • Common Stock

    0
  • Stock Options

    Exercise: $0.30Exp: 2017-11-21Common Stock (5,013,343 underlying)
    5,013,343
Footnotes (3)
  • [F1]Pursuant to Rule 16b-3 (right to buy); issued under the 2003 Stock Option Plan.
  • [F2]1,253,336 shares vest on each of 11/21/2008, 11/21/2009, and 11/21/2010; 1,253,335 shares vest on 11/21/2011.
  • [F3]Represents a portion of shares subject to an option to purchase an aggregate of 856,400 shares granted 11/21/07 (the "Option"). The Option vests in 4 equal annual installments commencing 11/21/08, but in addition to such vesting, is only exercisable to the extent the Issuer shares held in escrow in connection with its acquisition of Greenwich Therapeutics, Inc. are released. On 12/4/07, 35% of the total escrowed shares were released. The 299,754 shares identified above represents 35% of the total shares subject to the Option. Of these shares, 214,100 vest and will be exercisable on 11/21/08; 85,644 vest and will be exercisable 11/21/09.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -